Related references
Note: Only part of the references are listed.Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer
Jean Philippe Spano et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?
Fotios Loupakis et al.
CURRENT OPINION IN ONCOLOGY (2008)
Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial
Julien Taieb et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
An Inactivating Mutation in HDAC2 Leads to Dysregulation of Apoptosis Mediated by APAF1
Christin L. Hanigan et al.
GASTROENTEROLOGY (2008)
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Bernard Levin et al.
GASTROENTEROLOGY (2008)
Systemic treatment of colorectal cancer
Brian M. Wolpin et al.
GASTROENTEROLOGY (2008)
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
A. Walther et al.
GUT (2008)
Molecular classification and correlates in colorectal cancer
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci
Takako Kawasaki et al.
MODERN PATHOLOGY (2008)
Moving AHEAD with an international human epigenome project
Peter A. Jones et al.
NATURE (2008)
A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis
Thomas A. Down et al.
NATURE BIOTECHNOLOGY (2008)
HDAC2 deficiency and histone acetylation
Anne Hansen Ree et al.
NATURE GENETICS (2008)
Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
Woonbok Chung et al.
PLOS ONE (2008)
Pharmacogenetics in colorectal cancer: a systematic review
Silvia Funke et al.
PHARMACOGENOMICS (2008)
The methylome: approaches for global DNA methylation profiling
Stephan Beck et al.
TRENDS IN GENETICS (2008)
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening
Dao-Rong Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis
Timothy A. Chan et al.
PLOS MEDICINE (2008)
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Kohzoh Imai et al.
CARCINOGENESIS (2008)
Pharmacogenomics in colorectal cancer:: The first step for individualized-therapy
Eva Bandres et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Lanlan Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions
Zhaohui Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer
Kornel E. Schuebel et al.
PLOS GENETICS (2007)
TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
David Bacman et al.
BMC CANCER (2007)
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
Shirin Khambata-Ford et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I study of AZD0530, an oral potent inhibitor of Src kinase: First demonstration of inhibition of Src activity in human cancers
J. Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Thymidylate synthase polymorphisms and colon cancer:: Associations with tumor stage, tumor characteristics and survival
Karen Curtin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma
Shuji Ogino et al.
VIRCHOWS ARCHIV (2007)
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
F. Di Fiore et al.
BRITISH JOURNAL OF CANCER (2007)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
Multiple cancer prevalence: A growing challenge in long-term survivorship
Angela B. Mariotto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
The mammalian epigenome
Bradley E. Bernstein et al.
CELL (2007)
Targeting aberrant chromatin structure in colorectal carcinomas
Kazuo Konishi et al.
CANCER JOURNAL (2007)
Is molecular profiling ready for use in clinical decision making?
John P. A. Ioannidis
ONCOLOGIST (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
E. Miranda et al.
BRITISH JOURNAL OF CANCER (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression
Klaus-Peter Janssen et al.
GASTROENTEROLOGY (2006)
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2006)
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells
Tibor Rauch et al.
CANCER RESEARCH (2006)
Management of advanced colorectal cancer: state of the art
M. Saunders et al.
BRITISH JOURNAL OF CANCER (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer
Ruben Agrelo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer
Eriko Tokunaga et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Chromosomal instability, colorectal cancer and taxane resistance
Charles Swanton et al.
CELL CYCLE (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Tumor thymidylate synthase 1494de16 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment
E Dotor et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Profiling markers of prognosis in colorectal cancer
MS Lyall et al.
CLINICAL CANCER RESEARCH (2006)
Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer
CM Ulrich et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer
WS Samowitz et al.
GASTROENTEROLOGY (2005)
Molecular bias
JPA Ioannidis
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2005)
Why most published research findings are false
JPA Ioannidis
PLOS MEDICINE (2005)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype
JC Brandes et al.
CARCINOGENESIS (2005)
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
M Moroni et al.
LANCET ONCOLOGY (2005)
Histone deacetylase inhibitors in programmed cell death and cancer therapy
PA Marks et al.
CELL CYCLE (2005)
Low microsatellite instability is associated with poor prognosis in stage C colon cancer
MRJ Kohonen-Corish et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity
A Jakobsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular markers for diagnosis and prognosis
M Partridge et al.
CANCER AND METASTASIS REVIEWS (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Generating mutations but providing chemosensitivity:: the role of O6-methylguanine DNA methyltransferase in human cancer
M Esteller et al.
ONCOGENE (2004)
Systematic review of genetic influences on the prognosis of colorectal cancer
S Anwar et al.
BRITISH JOURNAL OF SURGERY (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Prospective evaluation of screening colonoscopy: who is being screened?
B Bressler et al.
GASTROINTESTINAL ENDOSCOPY (2004)
How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity
LC Seeff et al.
GASTROENTEROLOGY (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test
D Whitney et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
The staging of colorectal cancer: 2004 and beyond
CC Compton et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature
B Klump et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability
RL Ward et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Predicting aberrant CpG island methylation
FA Feltus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?
F Graziano et al.
ANNALS OF ONCOLOGY (2003)
Epigenetic inactivation of CHFR in human tumors
M Toyota et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer
G Kouraklis et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis
Y Miyakura et al.
GENES CHROMOSOMES & CANCER (2003)
Frequent hypermethylation of the 5 ' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer
PG Corn et al.
CARCINOGENESIS (2003)
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma
K Yamashita et al.
CANCER CELL (2002)
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
M van Rijnsoever et al.
GUT (2002)
The colorectal adenoma-carcinoma sequence
A Leslie et al.
BRITISH JOURNAL OF SURGERY (2002)
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
H Suzuki et al.
NATURE GENETICS (2002)
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
N Hawkins et al.
GASTROENTEROLOGY (2002)
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
M Esteller et al.
JOURNAL OF PATHOLOGY (2002)
Wnt/beta-catenin/Tcf signaling: A critical pathway in gastrointestinal tumorigenesis
FT Kolligs et al.
DIGESTION (2002)
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
B Iacopetta et al.
BRITISH JOURNAL OF CANCER (2001)
Guidelines 2000 for colon and rectal cancer surgery
H Nelson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer
E Villafranca et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
DM Scolnick et al.
NATURE (2000)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
R Gryfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer
CM Wright et al.
BRITISH JOURNAL OF SURGERY (2000)
p53 Gene mutation, microsatellite instability and adjuvant chemotherapy: Impact on survival of 388 patients with Dukes' C colon carcinoma
H Elsaleh et al.
ONCOLOGY (2000)
Share Paper
